Abstract #2627

The value of MRI in radiation therapy

Olga L Green¹, Hiram A Gay¹, Paragh Parikh¹, Stacie L Mackey², Sasa Mutic¹, Thomas G Dvergsten¹, Mo Kadbi³, and H Michael Gach¹

¹Radiation Oncology, Washington University in St Louis, St Louis, MO, United States, ²Radiation Oncology, Barnes-Jewish Hospital, St Louis, MO, United States, ³MRI, Philips Healthcare, Cleveland, OH, United States

During the last decade, the role of MRI in radiation therapy (RT) grew dramatically. The soft-tissue benefits from MRI simulations complement the geometric accuracy and photon attenuation maps from computed tomography in RT treatment planning. MR for calculating attenuation (MRCAT) is being used for MRI-only treatment planning. The clinical utilization of hybrid MRI-guided radiation therapy (MR-IGRT) systems began in January 2014. MR-IGRT enables real-time tracking of tumors and highly conformal treatments that enable improved patient outcomes. Hence, the value of MRI in RT is rapidly rising. Examples of MRI's role in, and value to, RT are presented.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.